Bone marrow-derived cells do not incorporate into the adult growing vasculature.

PubWeight™: 3.81‹?› | Rank: Top 1%

🔗 View Article (PMID 14656934)

Published in Circ Res on December 04, 2003

Authors

Tibor Ziegelhoeffer1, Borja Fernandez, Sawa Kostin, Matthias Heil, Robert Voswinckel, Armin Helisch, Wolfgang Schaper

Author Affiliations

1: Max-Planck-Institute for Clinical & Physiological Research, Bad Nauheim, Germany. t.ziegelhoeffer@kerckhoff.mpg.de

Articles citing this

(truncated to the top 100)

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A (2005) 6.16

Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol (2008) 4.07

Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest (2005) 3.95

Endothelial progenitor cells: identity defined? J Cell Mol Med (2009) 2.96

Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev (2008) 2.95

Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood (2004) 2.95

Collateral circulation: past and present. Basic Res Cardiol (2008) 2.60

Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev (2007) 2.60

Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A (2010) 2.49

Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat Protoc (2009) 2.34

Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res (2010) 2.30

Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. J Exp Med (2007) 2.25

Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med (2006) 2.05

Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ Res (2005) 2.04

Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci U S A (2005) 1.97

Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res (2010) 1.96

Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. J Am Coll Cardiol (2010) 1.92

Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J (2009) 1.82

Generation of functional blood vessels from a single c-kit+ adult vascular endothelial stem cell. PLoS Biol (2012) 1.79

Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J Clin Invest (2005) 1.74

In vivo models of angiogenesis. J Cell Mol Med (2006) 1.74

Angiogenesis, neurogenesis and brain recovery of function following injury. Curr Opin Investig Drugs (2010) 1.67

VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism. J Mol Med (Berl) (2008) 1.67

CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ Res (2010) 1.66

G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood (2006) 1.66

A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing. Blood (2011) 1.61

Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta (2009) 1.54

Cultured human bone marrow-derived CD31(+) cells are effective for cardiac and vascular repair through enhanced angiogenic, adhesion, and anti-inflammatory effects. J Am Coll Cardiol (2014) 1.47

The promise of cell-based therapies for diabetic complications: challenges and solutions. Circ Res (2010) 1.46

CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol (2006) 1.36

αV integrins in angiogenesis and cancer. Cold Spring Harb Perspect Med (2011) 1.33

Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo. J Appl Physiol (1985) (2008) 1.30

Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog Cardiovasc Dis (2007) 1.22

Influence of adult mesenchymal stem cells on in vitro vascular formation. Tissue Eng Part A (2009) 1.22

Breast tumour angiogenesis. Breast Cancer Res (2007) 1.22

CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. Tex Heart Inst J (2011) 1.21

Bone marrow cells recruited through the neuropilin-1 receptor promote arterial formation at the sites of adult neoangiogenesis in mice. J Clin Invest (2008) 1.20

The role IL-1 in tumor-mediated angiogenesis. Front Physiol (2014) 1.19

Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion. Microcirculation (2010) 1.18

Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol (2010) 1.16

Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res (2010) 1.16

Endothelial progenitor cell: a blood cell by many other names may serve similar functions. J Mol Med (Berl) (2013) 1.16

Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive trigger. Blood (2009) 1.15

Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implications. Microcirculation (2010) 1.15

The angiogenic response is dictated by beta3 integrin on bone marrow-derived cells. J Cell Biol (2008) 1.11

Bone marrow-derived cell regulation of skeletal muscle regeneration. FASEB J (2008) 1.11

Contribution of bone marrow-derived cells associated with brain angiogenesis is primarily through leukocytes and macrophages. Arterioscler Thromb Vasc Biol (2008) 1.11

Endothelial progenitor cells in atherosclerosis. Front Biosci (Landmark Ed) (2012) 1.09

Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. Invest Ophthalmol Vis Sci (2005) 1.08

Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J Cell Mol Med (2006) 1.07

Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction. Cardiovasc Res (2009) 1.05

In the hypoxic central nervous system, endothelial cell proliferation is followed by astrocyte activation, proliferation, and increased expression of the alpha 6 beta 4 integrin and dystroglycan. Glia (2010) 1.05

Heart repair and stem cells. J Physiol (2006) 1.04

Understanding vascular development. Wiley Interdiscip Rev Dev Biol (2012) 1.02

Hematopoietic stem cells contribute to lymphatic endothelium. PLoS One (2008) 1.01

Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFbeta1. Stem Cells Dev (2008) 1.01

Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplant (2009) 0.99

Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans. Arterioscler Thromb Vasc Biol (2009) 0.99

Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success. Dis Model Mech (2013) 0.99

The effect of erythropoietin on normal and neoplastic cells. Biologics (2012) 0.98

Lactate stimulates vasculogenic stem cells via the thioredoxin system and engages an autocrine activation loop involving hypoxia-inducible factor 1. Mol Cell Biol (2008) 0.98

The role of hypoxia in stem cell differentiation and therapeutics. J Surg Res (2009) 0.97

Exercise-induced Signals for Vascular Endothelial Adaptations: Implications for Cardiovascular Disease. Curr Cardiovasc Risk Rep (2012) 0.95

Suicide gene reveals the myocardial neovascularization role of mesenchymal stem cells overexpressing CXCR4 (MSC(CXCR4)). PLoS One (2012) 0.95

Vascular growth in health and disease. Front Mol Neurosci (2011) 0.94

Promotion of transplanted bone marrow-derived cell migration into the periodontal tissues due to orthodontic mechanical stress. Int J Med Sci (2013) 0.91

Macrophages in collateral arteriogenesis. Front Physiol (2012) 0.90

Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells. Am Heart J (2014) 0.90

Hematopoietic stem cell derived carcinoma-associated fibroblasts: a novel origin. Int J Clin Exp Pathol (2012) 0.89

Bone marrow mononuclear cells exert long-term neuroprotection in a rat model of ischemic stroke by promoting arteriogenesis and angiogenesis. Brain Behav Immun (2013) 0.89

Bone marrow-derived cell-specific chemokine (C-C motif) receptor-2 expression is required for arteriolar remodeling. Arterioscler Thromb Vasc Biol (2009) 0.88

Interactions between endothelial progenitor cells (EPC) and titanium implant surfaces. Clin Oral Investig (2012) 0.87

Myocardial regenerative properties of macrophage populations and stem cells. J Cardiovasc Transl Res (2012) 0.87

Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I. Am J Pathol (2007) 0.86

Regenerative cell therapy and pharmacotherapeutic intervention in heart failure: Part 1: Cardiovascular progenitor cells, their functions and sources. Neth Heart J (2008) 0.86

Growth and regression of vasculature in healthy and diabetic mice after hindlimb ischemia. Am J Physiol Regul Integr Comp Physiol (2012) 0.86

Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization. J Biomed Biotechnol (2012) 0.85

Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells. Stem Cell Res Ther (2012) 0.85

Reduced endothelial progenitor cells in European and South Asian men with atherosclerosis. Eur J Clin Invest (2007) 0.84

Cell transplantation for cardiac regeneration: where do we stand? Neth Heart J (2008) 0.84

Capillary arterialization requires the bone-marrow-derived cell (BMC)-specific expression of chemokine (C-C motif) receptor-2, but BMCs do not transdifferentiate into microvascular smooth muscle. Angiogenesis (2009) 0.84

Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells. Br J Pharmacol (2013) 0.84

Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2. Circ Res (2016) 0.83

Bone marrow-derived progenitor cells augment venous remodeling in a mouse dorsal skinfold chamber model. PLoS One (2012) 0.83

Transplantation of bone marrow derived monocytes: a novel approach for augmentation of arteriogenesis in a murine model of femoral artery ligation. Am J Transl Res (2013) 0.83

Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles. Expert Rev Cardiovasc Ther (2011) 0.83

Sexual dimorphism in epigenomic responses of stem cells to extreme fetal growth. Nat Commun (2014) 0.83

Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy. Regen Med (2011) 0.83

Hematopoietic stem cells are pluripotent and not just "hematopoietic". Blood Cells Mol Dis (2013) 0.83

Cell therapy with bone marrow cells for myocardial regeneration. Antioxid Redox Signal (2009) 0.83

Autologous bone-marrow mesenchymal stem cell implantation and endothelial function in a rabbit ischemic limb model. PLoS One (2013) 0.82

Monocytes are recruited from venules during arteriogenesis in the murine spinotrapezius ligation model. Arterioscler Thromb Vasc Biol (2014) 0.82

Clonal analysis reveals a common progenitor for endothelial, myeloid, and lymphoid precursors in umbilical cord blood. Circ Res (2010) 0.82

Brain and Retinal Pericytes: Origin, Function and Role. Front Cell Neurosci (2016) 0.81

Using C-arm x-ray imaging to guide local reporter probe delivery for tracking stem cell engraftment. Theranostics (2013) 0.81

Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease. Stem Cell Res Ther (2015) 0.81

Endothelial progenitor cells as factors in neovascularization and endothelial repair. World J Cardiol (2010) 0.80

Imaging stem cell therapy for the treatment of peripheral arterial disease. Curr Vasc Pharmacol (2012) 0.80

In vivo tracking of transplanted mononuclear cells using manganese-enhanced magnetic resonance imaging (MEMRI). PLoS One (2011) 0.79

Tetanus toxoid-pulsed monocyte vaccination for augmentation of collateral vessel growth. J Am Heart Assoc (2014) 0.79

Articles by these authors

The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell (2002) 4.72

Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest (2009) 4.12

Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation (2003) 3.55

Collateral circulation: past and present. Basic Res Cardiol (2008) 2.60

Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol (2010) 2.55

Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res (2008) 2.51

Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell (2011) 2.51

Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell Stem Cell (2008) 2.41

Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat Protoc (2009) 2.34

The range of adaptation by collateral vessels after femoral artery occlusion. Circ Res (2006) 2.31

Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol (2002) 2.21

Role of extracellular RNA in atherosclerotic plaque formation in mice. Circulation (2013) 2.18

Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler Thromb Vasc Biol (2006) 2.17

S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. Cardiovasc Res (2007) 2.15

Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res (2004) 2.08

Bone marrow-derived cells contribute to infarct remodelling. Cardiovasc Res (2006) 2.00

Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol (2002) 1.99

Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J Am Coll Cardiol (2004) 1.88

Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res (2004) 1.87

VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res (2003) 1.82

Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J (2007) 1.81

Arteriogenesis: the development and growth of collateral arteries. Microcirculation (2003) 1.78

Abnormalities in intracellular Ca2+ regulation contribute to the pathomechanism of Tako-Tsubo cardiomyopathy. Eur Heart J (2009) 1.78

Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol (2006) 1.76

Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell (2011) 1.72

Gap junctional remodeling by hypoxia in cultured neonatal rat ventricular myocytes. Cardiovasc Res (2005) 1.70

Mouse gridlock: no aortic coarctation or deficiency, but fatal cardiac defects in Hey2 -/- mice. Curr Biol (2002) 1.70

Arteriogenesis is associated with an induction of the cardiac ankyrin repeat protein (carp). Cardiovasc Res (2003) 1.59

Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med (2009) 1.58

Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation (2007) 1.57

Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler Thromb Vasc Biol (2004) 1.51

Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res (2008) 1.49

Lack of ecto-5'-nucleotidase (CD73) promotes arteriogenesis. Cardiovasc Res (2012) 1.46

p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J (2002) 1.46

Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis. J Clin Invest (2006) 1.46

Differential expression of GAPDH and beta3-actin in growing collateral arteries. Mol Cell Biochem (2002) 1.45

Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension. FASEB J (2005) 1.44

Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study. J Am Coll Cardiol (2004) 1.42

The prognostic significance of inspiratory capacity in pulmonary arterial hypertension. Respiration (2014) 1.41

Downregulation of apoptosis-inducing factor in harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circ Res (2005) 1.41

Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. J Control Release (2002) 1.40

A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res (2004) 1.32

Myf5-positive satellite cells contribute to Pax7-dependent long-term maintenance of adult muscle stem cells. Cell Stem Cell (2013) 1.29

Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 1.29

Angiopoietin-2 impairs revascularization after limb ischemia. Circ Res (2007) 1.29

Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy. Circulation (2007) 1.28

Exogenous application of transforming growth factor beta 1 stimulates arteriogenesis in the peripheral circulation. FASEB J (2002) 1.26

Sca1-derived cells are a source of myocardial renewal in the murine adult heart. Stem Cell Reports (2013) 1.25

Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles. Int J Cardiol (2010) 1.25

Mechanisms of arteriogenesis. Acta Biochim Biophys Sin (Shanghai) (2008) 1.23

Bone marrow transplantation demonstrates medullar origin of CD34+ fibrocytes and ameliorates hepatic fibrosis in Abcb4-/- mice. Hepatology (2010) 1.22

H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway. Eur J Cell Biol (2005) 1.21

Circulating vascular progenitor cells do not contribute to compensatory lung growth. Circ Res (2003) 1.21

Endothelial nitric oxide synthase activity is essential for vasodilation during blood flow recovery but not for arteriogenesis. Arterioscler Thromb Vasc Biol (2007) 1.21

Contrasting expression of canonical Wnt signaling reporters TOPGAL, BATGAL and Axin2(LacZ) during murine lung development and repair. PLoS One (2011) 1.20

Platelet-derived growth factor receptor-β-positive telocytes in skeletal muscle interstitium. J Cell Mol Med (2012) 1.20

The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol (2008) 1.19

Delayed arteriogenesis in hypercholesterolemic mice. Circulation (2005) 1.19

Continuous endothelial cell activation increases angiogenesis: evidence for the direct role of endothelium linking angiogenesis and inflammation. J Vasc Res (2006) 1.17

Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. Arthritis Rheum (2010) 1.17

Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am J Physiol Heart Circ Physiol (2002) 1.16

A critical review of clinical arteriogenesis research. J Am Coll Cardiol (2009) 1.14

Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells (2006) 1.13

Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells. J Cell Physiol (2004) 1.12

Mechanosensitive p27Kip1 regulation and cell cycle entry in vascular smooth muscle cells. Circulation (2003) 1.12

A common MLP (muscle LIM protein) variant is associated with cardiomyopathy. Circ Res (2009) 1.11

Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension. J Am Coll Cardiol (2006) 1.11

Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement. Anesth Analg (2010) 1.10

Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol (2004) 1.10

SLC4A11 prevents osmotic imbalance leading to corneal endothelial dystrophy, deafness, and polyuria. J Biol Chem (2010) 1.10

Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in mice. J Clin Invest (2011) 1.10

Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension. J Heart Lung Transplant (2011) 1.09

Influence of inflammatory cytokines on arteriogenesis. Microcirculation (2003) 1.09

Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heart. Circ Res (2011) 1.07

Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor. Blood (2007) 1.07

Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway. J Cell Physiol (2007) 1.07

CD34+ progenitor to endothelial cell transition in post-pneumonectomy angiogenesis. Am J Respir Cell Mol Biol (2011) 1.05

Participation of bone marrow-derived cells in long-term repair processes after experimental stroke. J Cereb Blood Flow Metab (2003) 1.05